TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Lars Bertram, Rik Vandenberghe et al.|Alzheimer s & Dementia|2021Cited by 43
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF‐AD studyRebecca G. Smith, Katie Lunnon, Ehsan Pishva et al.|Alzheimer s & Dementia|2024Cited by 16
The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohortsVeerle van Gils, Stephanie J. B. Vos, Willemijn J. Jansen et al.|Alzheimer s & Dementia|2025Cited by 0
The evolution of Alzheimer’s target identification: Towards a fusion of artificial and cellular intelligenceGayle Wittenberg, Simon Lovestone, Fiona Elwood et al.|The Journal of Prevention of Alzheimer s Disease|2025Cited by 0